261 related articles for article (PubMed ID: 31032345)
21. High expression levels of miR-21 and miR-210 predict unfavorable survival in breast cancer: a systemic review and meta-analysis.
Tang Y; Zhou X; Ji J; Chen L; Cao J; Luo J; Zhang S
Int J Biol Markers; 2015 Nov; 30(4):e347-58. PubMed ID: 26349663
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of microRNA-135 in patients with digestive system cancers: a systematic review and meta-analysis.
Chao C; Sang C; Wang M; Wang Z; Li Y; Luo G; Zhang X
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31803920
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of miR-21 for prostate cancer: a systematic review and meta-analysis.
Stafford MYC; Willoughby CE; Walsh CP; McKenna DJ
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34931228
[TBL] [Abstract][Full Text] [Related]
24. Prognostic and clinicopathological significance of microRNA-21 overexpression in breast cancer: a meta-analysis.
Pan F; Mao H; Deng L; Li G; Geng P
Int J Clin Exp Pathol; 2014; 7(9):5622-33. PubMed ID: 25337203
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of the MicroRNA-29 family in multiple human cancers: A meta-analysis and systematic review.
Qi Y; Huang Y; Pang L; Gu W; Wang N; Hu J; Cui X; Zhang J; Zhao J; Liu C; Zhang W; Zou H; Li F
Clin Exp Pharmacol Physiol; 2017 Apr; 44(4):441-454. PubMed ID: 28063172
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of low microRNA-34a expression in human gastrointestinal cancer: a systematic review and meta-analysis.
Chen YL; Liu XL; Li L
BMC Cancer; 2021 Jan; 21(1):63. PubMed ID: 33446130
[TBL] [Abstract][Full Text] [Related]
27. The Prognostic Value of Small Noncoding microRNA-21 Expression in the Survival of Cancer Patients: A Meta-Analysis.
Binabaj MM; Bahrami A; Khazaei M; Avan A; Ferns GA; Soleimanpour S; Ryzhikov M; Hassanian SM
Crit Rev Eukaryot Gene Expr; 2020; 30(3):207-221. PubMed ID: 32749107
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Value of MicroRNA-196a in Asian Cancer Patients: a Meta-Analysis.
Cai X; Liu X; Lu N; Xiao M; Li Z
Clin Lab; 2016 Nov; 62(11):2257-2265. PubMed ID: 28164681
[TBL] [Abstract][Full Text] [Related]
29. MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis.
Lü L; Mao X; Shi P; He B; Xu K; Zhang S; Wang J
Medicine (Baltimore); 2017 Jun; 96(22):e7085. PubMed ID: 28562579
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of microRNA-21 in pancreatic ductal adenocarcinoma: a meta-analysis.
Hu GY; Tao F; Wang W; Ji KW
World J Surg Oncol; 2016 Mar; 14():82. PubMed ID: 26969625
[TBL] [Abstract][Full Text] [Related]
31. Change of Circulating and Tissue-Based miR-20a in Human Cancers and Associated Prognostic Implication: A Systematic Review and Meta-Analysis.
Zhang Q; Wang Q; Sun W; Gao F; Liu L; Cheng L; Li Z
Biomed Res Int; 2018; 2018():6124927. PubMed ID: 30596096
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Role of microRNA-21 Expression in Brain Tumors: a Meta-analysis.
He XY; Liao YD; Guo XQ; Wang R; Xiao ZY; Wang YG
Mol Neurobiol; 2016 Apr; 53(3):1856-1861. PubMed ID: 25790954
[TBL] [Abstract][Full Text] [Related]
33. Prognostic and clinicopathological significance of MicroRNA-153 in human cancers: A meta-analysis.
Huang M; Li C; Kong F; Wu Y; Yuan Q; Hu L
Medicine (Baltimore); 2020 Nov; 99(46):e22833. PubMed ID: 33181653
[TBL] [Abstract][Full Text] [Related]
34. Correlation between miR-200 Family Overexpression and Cancer Prognosis.
Liu W; Zhang K; Wei P; Hu Y; Peng Y; Fang X; He G; Wu L; Chao M; Wang J
Dis Markers; 2018; 2018():6071826. PubMed ID: 30069274
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
[TBL] [Abstract][Full Text] [Related]
36. Nestin Expression Is Associated with Poor Clinicopathological Features and Prognosis in Glioma Patients: an Association Study and Meta-analysis.
Lv D; Lu L; Hu Z; Fei Z; Liu M; Wei L; Xu J
Mol Neurobiol; 2017 Jan; 54(1):727-735. PubMed ID: 26768429
[TBL] [Abstract][Full Text] [Related]
37. The prognostic significance of PD-L1 expression in patients with glioma: A meta-analysis.
Xue S; Song G; Yu J
Sci Rep; 2017 Jun; 7(1):4231. PubMed ID: 28652622
[TBL] [Abstract][Full Text] [Related]
38. Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis.
Fu X; Han Y; Wu Y; Zhu X; Lu X; Mao F; Wang X; He X; Zhao Y; Zhao Y
Eur J Clin Invest; 2011 Nov; 41(11):1245-53. PubMed ID: 21521185
[TBL] [Abstract][Full Text] [Related]
39. microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis.
Frampton AE; Krell J; Jamieson NB; Gall TM; Giovannetti E; Funel N; Mato Prado M; Krell D; Habib NA; Castellano L; Jiao LR; Stebbing J
Eur J Cancer; 2015 Jul; 51(11):1389-404. PubMed ID: 26002251
[TBL] [Abstract][Full Text] [Related]
40. Decreased expression of microRNA-107 predicts poorer prognosis in glioma.
Ji Y; Wei Y; Wang J; Ao Q; Gong K; Zuo H
Tumour Biol; 2015 Jun; 36(6):4461-6. PubMed ID: 25596705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
